Delivering reliable patient access, experienced investigators, and efficient trial execution serving Merrillville, Indiana and the greater Chicagoland area.
Delivering reliable patient access, experienced investigators, and efficient trial execution serving Merrillville, Indiana and the greater Chicagoland area.
Indiana Medical Research Institute is a dedicated clinical research center located in Merrillville, Indiana, within the greater Chicagoland area. The site combines the agility of a growing research institution with the extensive clinical expertise of Dr. Arshad P. Malik, a board-certified cardiologist with decades of experience caring for patients in the community.
As a proud member of ECN Clinical, Indiana Medical Research Institute operates under centralized SOPs, unified contracting, and network-wide quality standards, giving sponsors the consistency of a national network with the accountability of a dedicated local site.
Indiana Medical Research Institute specializes in cardiovascular clinical trials with deep expertise across atrial fibrillation, heart failure, and high-risk cardiovascular populations. The site is actively expanding into hypogonadism and migraine research, demonstrating adaptability and growth across multiple therapeutic indications.
Our patient recruitment infrastructure combines technology, community relationships, and dedicated outreach to deliver consistent enrollment performance across every study we support.
Indiana Medical Research Institute serves a diverse adult and geriatric population ranging from 18 to over 80 years old across Merrillville and the greater Chicagoland area. Our location on Broadway gives participants from across Northwest Indiana a convenient clinical research center near them, with study teams committed to flexible scheduling and patient-centered care.
Our Merrillville location within the greater Chicagoland area gives Indiana Medical Research Institute access to one of the Midwest's most diverse regional communities. Our patient population reflects broad representation across White, African American, and Hispanic communities, helping sponsors meet FDA diversity requirements and build more inclusive development programs.
Diversity in clinical research is a commitment to the communities we serve. Our sites are chosen and structured to reflect the communities they serve, ensuring every study benefits from genuine local representation, trust, and accessibility.
Our network capability deck or TA-specific one-pagers to share with your team.
Yes. Indiana Medical Research Institute offers paid research studies in Merrillville and across the greater Chicagoland area. Compensation varies by study and will be explained clearly before you enroll. Study-related medical care and visits are always at no cost to participants.
Indiana Medical Research Institute is located at 8550 Broadway, Suite A, Merrillville, IN 46410, serving participants across a 40-mile catchment radius throughout Northwest Indiana and the greater Chicago area.
Indiana Medical Research Institute is a CLIA-certified research facility offering Phase II through IV clinical trial capabilities. Our site includes onsite ECG, temperature-controlled drug storage, DEA licensing, CTMS and multiple EDC platforms, eConsent, on-site laboratory with standard and -70C freezers, and specialty procedures including biopsies, PK sampling, spirometry, oscillometry, FeNO, and certified FibroScan.
Indiana Medical Research Institute leads in cardiology clinical research with deep expertise across atrial fibrillation, heart failure, and cardiac imaging. The site also conducts respiratory clinical research, endocrine clinical research in Indiana, rheumatology clinical research, dermatology clinical research in Indiana, and men's health clinical research. The site is actively expanding into hypogonadism and migraine research, with Dr. Malik bringing over 50 years of cardiovascular expertise to every study.
As a trusted clinical research site in Indiana and member of the ECN Clinical, Indiana Medical Research Institute operates under centralized SOPs, unified contracting, and network-wide quality standards. Sponsors benefit from study activation within 2 to 4 weeks, 24-hour turnaround on all communications, a proven 85% screen to enroll rate, and a highly protocol-driven team committed to data quality and sponsor responsiveness.
